| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_465b607edb4c88aeefb4958e154efaec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_050fc7b82c5d17d9aeb63a7cdcc546b3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 |
| filingDate |
2019-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe44c21d654d7310ccbf82b263686acb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e3a7752d7b8d7f452e4d40422d42547
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39bea52657b68836fd7174abd871701b |
| publicationDate |
2020-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020009444-A1 |
| titleOfInvention |
Gene and cell therapy product using cell fusion technology and use thereof |
| abstract |
The present invention relates to a gene and cell therapy product using a cell fusion technology and a use thereof. More particularly, cells which overexpress hemagglutinin neuraminidase (HN) and F (fusion) protein were found to have an improved cell fusion potential with other cells thanks to the HN and F proteins and restore cells that have been damaged or are undergoing death, or genetically aberrant cells to normal cells through cell fusion therewith. Thus, a vector carrying a gene coding for the HN/F protein or cells transformed therewith can be advantageously used as an effective ingredient of a composition for prevention or treatment of cell damage-related diseases, such as neurodegenerative diseases or neuropathy, or muscular degenerative diseases or myopathy. |
| priorityDate |
2018-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |